Latest Headlines
-
Countable Labs Launches Category-Defining, Highly Sensitive PCR Platform — Countable PCR — Finally Quantifying Rare Events, Even From Limited Samples
5/13/2025
Countable Labs (formerly Enumerix) enters the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection.
-
QIAGEN Enhances Leading Clinical Genomics Portfolio With Acquisition Of Genoox AI-Powered Software
5/12/2025
QIAGEN today announced it has signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.
-
Agappe Diagnostics And Fujirebio- Japan: Advancing CLEIA-Based Immunoassay Testing
5/12/2025
In a groundbreaking collaboration, Agappe Diagnostics Ltd and Fujirebio Inc., Japan are reshaping the future of laboratory diagnostics.
-
Solution 2.8.0 Release For The Prime Liquid Handler
5/9/2025
At HighRes Biosolutions, our commitment to innovation drives us to continuously refine our software solutions, ensuring they meet the evolving needs of modern laboratories.
-
OmniAb Introduces The xPloration Partner Access Program
5/8/2025
OmniAb, Inc. today introduced the launch of the xPloration Partner Access Program, under which current OmniAb partners can purchase the xPloration instrument to significantly enhance their capabilities in antibody discovery and development.
-
Nordic Bioscience Announces PRO-C3 Launched By Roche Diagnostics On Cobas Analysers
5/8/2025
Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT formula (age, diabetes status, PRO-C3, platelets), assesses liver fibrosis severity – a disease responsible for approximately one in every 25 deaths worldwide.
-
Eurofins Viracor Revolutionizes Respiratory Diagnostics With New BAL Specimen Type For NeXGen® Fungal / AFB NGS Assay
5/7/2025
Eurofins Viracor, a leading specialty diagnostics laboratory, is proud to announce a groundbreaking advancement in respiratory infection diagnostics with the launch of a new bronchoalveolar lavage (BAL) specimen type for its NeXGen® Fungal / Acid Fast Bacteria Next Generation Sequencing (NGS) assay.
-
Histofy And Source Bioscience UK Announce Strategic Partnership To Advance AI-Powered Pathology In The UK
5/6/2025
Histofy, a leading UK based pathology AI company focused on accelerating histopathology workflows in both clinical and pharmaceutical sectors, is proud to announce a strategic partnership with Source BioScience UK Limited, the largest histopathology service provider in the United Kingdom.
-
Molecular Devices Launches Automated QPix FLEX Microbial Colony Picking System
5/6/2025
Molecular Devices, LLC., a leading high-performance life science solutions provider, today launched the QPix® FLEX™ Microbial Colony Picking System.
-
Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance
5/6/2025
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces significant expansion of its blood volume analysis (BVA) capabilities in three new hospitals.